Kuehn Law Encourages Investors of Intellia Therapeutics, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - August 16, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Intellia Therapeutics, Inc. (NASDAQ: NTLA) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you are a long-term NTLA stockholder please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call...
2024-08-16 9:16 AM EDT
Kuehn Law Encourages Investors of Relmada Therapeutics, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - August 14, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Relmada Therapeutics, Inc. (NASDAQ: RLMD) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you are a long-term RLMD stockholder please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call...
2024-08-14 10:30 AM EDT
Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - August 14, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you are a long-term ZNTL stockholder please contact Justin Kuehn, Esq. by email at justin@kuehn.law or...
2024-08-14 10:24 AM EDT
Kuehn Law Encourages Investors of SpringWorks, Therapeutics Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - August 14, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you are a long-term SWTX stockholder please contact Justin Kuehn, Esq. by email at justin@kuehn.law or...
2024-08-14 10:19 AM EDT
Kuehn Law Encourages Investors of Five Below, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - August 7, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Five Below, Inc. (NASDAQ: FIVE) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Five Below insiders caused the company to misrepresent or fail to disclose the true nature of the company's financial strength and operations, including its outlook for the first quarter and full year 2024....
2024-08-07 12:16 PM EDT
Kuehn Law Encourages Investors of Owlet, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - August 7, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Owlet, Inc. (NYSE: OWLT) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Owlet insiders caused the company to misrepresent or fail to disclose that (1) Owlet was reasonably likely to be required to obtain marketing authorization for the Smart Sock because the FDA concluded it was a...
2024-08-07 10:37 AM EDT
Kuehn Law Encourages Investors of Mobileye Global Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - July 22, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Mobileye Global Inc. (NASDAQ: MBLY) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Mobileye Global insiders caused the company to misrepresent or fail to disclose that (1) to avoid the shortages experienced amid supply chain constraints in 2021 and 2022, the company's Tier 1 customers...
2024-07-22 8:46 AM EDT
Kuehn Law Encourages Investors of AlloVir, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - July 22, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of AlloVir, Inc. (NASDAQ: ALVR) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, AlloVir insiders caused the company to misrepresent or fail to disclose that (i) the posoleucel Phase 3 Studies were unlikely to meet their primary endpoints; (ii) as a result, it was likely that the company...
2024-07-22 8:46 AM EDT
Kuehn Law Encourages Investors of Assertio Holdings, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - July 22, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Assertio Holdings, Inc. (NASDAQ: ASRT) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Assertio Holdings insiders caused the company to misrepresent or fail to disclose (i) the company's reliance on Indocin products to boost its net income was unsustainable given the risk of generic...
2024-07-22 8:46 AM EDT
Kuehn Law Encourages Investors of Amplitude, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - July 22, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Amplitude, Inc. (NASDAQ: AMPL) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Amplitude insiders caused the company to misrepresent or fail to disclose that (1) Amplitude's land-and-expand strategy was years away from significantly accelerating revenues among its newer client cohorts;...
2024-07-22 8:46 AM EDT
Kuehn Law Encourages Investors of Apellis Pharmaceuticals, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - July 2, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Apellis insiders caused the company to misrepresent or fail to disclose that (1) the design of SYFOVRE's clinical trials was insufficient to identify incidents of retinal vasculitis in patients...
2024-07-02 9:58 AM EDT
Kuehn Law Encourages Investors of Amylyx Pharmaceuticals, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - July 2, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Amylyx insiders caused the company to misrepresent or fail to disclose that (i) RELYVRIO's commercial prospects were overstated; (ii) patients were discontinuing treatment with RELYVRIO after six...
2024-07-02 9:55 AM EDT
Kuehn Law Encourages Investors of Roblox Corporation to Contact Law Firm
New York, New York--(Newsfile Corp. - July 2, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Roblox Corporation (NYSE: RBLX) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Roblox insiders caused the company to misrepresent or fail to disclose that (1) the Roblox platform suffered from a lack of adequate content filters and did not impose limits on user expenditures; (2) this...
2024-07-02 9:52 AM EDT
Kuehn Law Encourages Investors of LivePerson, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - July 2, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of LivePerson, Inc. (NASDAQ: LPSN) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, LivePerson insiders caused the company to (i) maintain a significant deficiency in its disclosure controls and procedures; (ii) as a consequence, LivePerson's internal controls over financial reporting were...
2024-07-02 9:48 AM EDT
Kuehn Law Encourages Investors of Schrodinger, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - May 16, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Schrodinger, Inc. (NASDAQ: SDGR) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own SDGR please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The consultation and...
2024-05-16 10:39 AM EDT
Kuehn Law Encourages Investors of Relmada Therapeutics, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - May 16, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Relmada Therapeutics, Inc. (NASDAQ: RLMD) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own RLMD please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The...
2024-05-16 10:37 AM EDT
Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - May 16, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own ZNTL please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The...
2024-05-16 10:36 AM EDT
Kuehn Law Encourages Investors of ImmunityBio, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - May 16, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of ImmunityBio, Inc. (NASDAQ: IBRX) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own IBRX please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The consultation and...
2024-05-16 10:33 AM EDT
Kuehn Law Encourages Investors of Intellia Therapeutics, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - May 16, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Intellia Therapeutics, Inc. (NASDAQ: NTLA) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own NTLA please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The...
2024-05-16 10:31 AM EDT
Kuehn Law Encourages Investors of Regeneron Pharmaceuticals, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - May 16, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own REGN please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The...
2024-05-16 10:28 AM EDT